Literature DB >> 3852685

Danazol in acquired amegakaryocytic thrombocytopenic purpura: a case report.

W Kayser, H H Euler, N Schmitz, W Gassmann, H Löffler, F Asbeck.   

Abstract

Acquired amegakaryocytic thrombocytopenic purpura is a rare disease. Most reported patients did not respond to any therapeutical approach. Recently we observed a striking improvement of this disorder in a female patient shortly after therapy with danazol had been initiated. This observation and its possible implication for the treatment of amegakaryocytic thrombocytopenia are reported herein.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3852685     DOI: 10.1007/bf00320726

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  5 in total

1.  Successful treatment of amegakaryocytic thrombocytopenic purpura with cyclosporine.

Authors:  W Hill; R Landgraf
Journal:  N Engl J Med       Date:  1985-04-18       Impact factor: 91.245

2.  Acquired hypomegakaryocytic thrombocytopenic purpura. Occurrence in a patient with absent thrombopoietic stimulating factor.

Authors:  E H Hirsh; W R Vogler; T P McDonald; S F Stein
Journal:  Arch Intern Med       Date:  1980-05

3.  Thrombocytopenia with decreased megakaryocytes. Evaluation and prognosis.

Authors:  D B Stoll; S Blum; D Pasquale; S Murphy
Journal:  Ann Intern Med       Date:  1981-02       Impact factor: 25.391

4.  Acquired amegakaryocytic thrombocytopenic purpura: a syndrome of diverse etiologies.

Authors:  R Hoffman; E Bruno; J Elwell; E Mazur; A M Gewirtz; P Dekker; A E Denes
Journal:  Blood       Date:  1982-11       Impact factor: 22.113

5.  Danazol for the treatment of idiopathic thrombocytopenic purpura.

Authors:  Y S Ahn; W J Harrington; S R Simon; R Mylvaganam; L M Pall; A G So
Journal:  N Engl J Med       Date:  1983-06-09       Impact factor: 91.245

  5 in total
  3 in total

1.  Anti-CD20 Antibody is Effective in the Patient with Refractory Amegakaryocytic Thrombocytopenia, 25 Months Follow up.

Authors:  Mehrzad Mirzania; Sedigheh Khalili; Akbar Hasanpoor; Ahmad Reza Shamshiri
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2014

2.  Good response to cyclosporin in a child with acquired thrombocytopenic purpura.

Authors:  Shuchita Jain; Seema Kapoor; Ankur Singh; R N Mandal Ravi; Silky Jain
Journal:  Indian J Pediatr       Date:  2011-12-15       Impact factor: 5.319

3.  Danazol: an effective option in acquired amegakaryocytic thrombocytopaenic purpura.

Authors:  E Mulroy; S Gleeson; S Chiruka
Journal:  Case Rep Hematol       Date:  2015-04-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.